BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32103448)

  • 1. Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design.
    Yuan S; Fan K; Chen Z; Sun Y; Hou H; Zhu L
    Virol Sin; 2020 Aug; 35(4):445-454. PubMed ID: 32103448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
    Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
    J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
    Lockbaum GJ; Henes M; Lee JM; Timm J; Nalivaika EA; Thompson PR; Kurt Yilmaz N; Schiffer CA
    Biochemistry; 2021 Oct; 60(39):2925-2931. PubMed ID: 34506130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93.
    Costenaro L; Kaczmarska Z; Arnan C; Janowski R; Coutard B; Solà M; Gorbalenya AE; Norder H; Canard B; Coll M
    J Virol; 2011 Oct; 85(20):10764-73. PubMed ID: 21835784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues.
    Wang J; Fan T; Yao X; Wu Z; Guo L; Lei X; Wang J; Wang M; Jin Q; Cui S
    J Virol; 2011 Oct; 85(19):10021-30. PubMed ID: 21813612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
    Binford SL; Weady PT; Maldonado F; Brothers MA; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4366-73. PubMed ID: 17908951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups.
    Croft SN; Walker EJ; Ghildyal R
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
    Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
    Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
    J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease.
    Patick AK; Binford SL; Brothers MA; Jackson RL; Ford CE; Diem MD; Maldonado F; Dragovich PS; Zhou R; Prins TJ; Fuhrman SA; Meador JW; Zalman LS; Matthews DA; Worland ST
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2444-50. PubMed ID: 10508022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.
    Rocha-Pereira J; Nascimento MS; Ma Q; Hilgenfeld R; Neyts J; Jochmans D
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4675-81. PubMed ID: 24890597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
    Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection.
    Zhang XN; Song ZG; Jiang T; Shi BS; Hu YW; Yuan ZH
    World J Gastroenterol; 2010 Jan; 16(2):201-9. PubMed ID: 20066739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir.
    Hung HC; Wang HC; Shih SR; Teng IF; Tseng CP; Hsu JT
    J Infect Dis; 2011 Jun; 203(12):1784-90. PubMed ID: 21536800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir.
    Lacroix C; George S; Leyssen P; Hilgenfeld R; Neyts J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5814-8. PubMed ID: 26055377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
    Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
    Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor.
    Zalman LS; Brothers MA; Dragovich PS; Zhou R; Prins TJ; Worland ST; Patick AK
    Antimicrob Agents Chemother; 2000 May; 44(5):1236-41. PubMed ID: 10770757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease.
    Liu M; Xu B; Ma Y; Shang L; Ye S; Wang Y
    Antiviral Res; 2021 Aug; 192():105102. PubMed ID: 34082057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.